What it is
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog used in TWW's body composition protocols. In simple terms, it is meant to support visceral adiposity and growth-hormone-axis signaling. Some peptides act like small biological messages, while others support peptide-adjacent pathways such as mitochondrial function, redox balance, or hormone signaling.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone. Natural growth hormone-releasing hormone is made in the hypothalamus and tells the pituitary gland to release growth hormone.
The practical goal is to understand what signal this peptide is trying to send, then decide whether that signal matches the person's goals, labs, symptoms, and overall health picture.
What it may help with
The larger idea is changing body composition by influencing visceral fat, growth-hormone-axis signaling, recovery, and lean-mass support while the patient also trains and eats appropriately. For Tesamorelin, the suspected benefits come from the way this pathway appears to influence visceral adiposity and growth-hormone-axis signaling. These are not guaranteed outcomes, but they explain why the peptide is considered in certain wellness protocols.
What it’s used for
In peptide protocols, this is usually considered as part of a broader plan rather than as a stand-alone “magic bullet.” At TWW, that means matching the peptide to the clinical pattern, the goal of care, and the other pieces of the plan such as nutrition, training, sleep, lab review, or recovery work.
- Body-composition protocols where visceral adiposity, low insulin-like growth factor 1 (IGF-1) patterns, or recovery goals are relevant.
- Patients with objective tracking through waist, InBody/body composition, glucose/insulin markers, and insulin-like growth factor 1 (IGF-1).
- Programs paired with resistance training and nutrition.